跳至主要内容
临床试验/IRCT20200313046756N1
IRCT20200313046756N1招募中3 期

Effects of 4 months of 25 Hydroxy vitamin D3 supplementation and probiotics independently and concomitantly on some factors affecting cancer progression in patients with breast cancer undergoing surgery referred to Shahid Bahonar Hospital in Kerman.

Kerman University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Women over 18 years with clinical stage II and III breast cancer diagnosis.
  • Undergoing Neo-adjuvant Treatment and Surgery.

排除标准

  • Age less than 18 years
  • Stages I and IV of Breast Cancer
  • Non-surgical advanced or metastatic cancers
  • Cancer with a Basal-like Molecular Pattern
  • Patients who have been taking vitamin D or probiotic supplements for the past three months.
  • People with hyperparathyroidism or hypoparathyroidism
  • active Kidney stones in the past six months
  • Renal Failure (Creatinine> 190mmol / L)
  • Hypercalcemia
  • History of taking part in other intervention tests.
  • Hormone therapy history.
  • History of radiotherapy
  • Recent use of estrogenic drugs such as birth control pills
  • Chronic diarrhea or constipation (over 4 consecutive weeks)
  • History of inflammatory bowel disease
  • Celiac disease, chronic pancreatitis, history of colectomy and ileostomy
  • History of gallstones
  • Liver Failures
  • Known cases of AIDS
  • Continuous and long-term use of antibiotics, consumption of aluminum hydroxate
  • History of Thiazide diuretics

研究者

相似试验